Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Craig Miller

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Obstetrics and Gynecology|July 5, 2011
Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal womenKevin Holcomb, Zivjena Vucetic, M Craig Miller, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2018
The Parsortix™ Cell Separation System-A versatile liquid biopsy platformM Craig Miller, Peggy S Robinson, Christopher Wagner, et al.
Journal of Oncology|December 18, 2009
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerM Craig Miller, Gerald V Doyle, Leon W M M Terstappen
Urology|October 18, 2002
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancerRobert W Veltri, M Craig Miller, Gerard J O'dowd, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 4, 2007
Statistical considerations for enumeration of circulating tumor cellsArjan G J Tibbe, M Craig Miller, Leon W M M Terstappen
The Prostate|July 13, 2010
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomyRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
The Journal of Urology|December 13, 2002
Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice studyJoseph C Presti, Gerard J O'Dowd, M Craig Miller, et al.
Cancer Reports (Hoboken, N.J.)|June 27, 2020
Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate CancerNeil M Carleton, Guangjing Zhu, M Craig Miller, et al.
Cancer|October 8, 2004
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomyCraig G Rogers, Masood A Khan, M Craig Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometryRobert W Veltri, M Craig Miller, Sumit Isharwal, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Obstetrics and Gynecology|July 5, 2011
Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal womenKevin Holcomb, Zivjena Vucetic, M Craig Miller, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2018
The Parsortix™ Cell Separation System-A versatile liquid biopsy platformM Craig Miller, Peggy S Robinson, Christopher Wagner, et al.
Journal of Oncology|December 18, 2009
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerM Craig Miller, Gerald V Doyle, Leon W M M Terstappen
Urology|October 18, 2002
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancerRobert W Veltri, M Craig Miller, Gerard J O'dowd, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 4, 2007
Statistical considerations for enumeration of circulating tumor cellsArjan G J Tibbe, M Craig Miller, Leon W M M Terstappen
The Prostate|July 13, 2010
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomyRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
The Journal of Urology|December 13, 2002
Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice studyJoseph C Presti, Gerard J O'Dowd, M Craig Miller, et al.
Cancer Reports (Hoboken, N.J.)|June 27, 2020
Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate CancerNeil M Carleton, Guangjing Zhu, M Craig Miller, et al.
Cancer|October 8, 2004
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomyCraig G Rogers, Masood A Khan, M Craig Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometryRobert W Veltri, M Craig Miller, Sumit Isharwal, et al.
Pageof 6